{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:21:01Z","timestamp":1789348861561,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Youth Medical Innovation and Practice Research Program of Guangzhou","award":["2023QNYXZD001"],"award-info":[{"award-number":["2023QNYXZD001"]}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["ES-2024-171-01"],"award-info":[{"award-number":["ES-2024-171-01"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073294"],"award-info":[{"award-number":["82073294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gene.2025.149590","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T19:41:15Z","timestamp":1747856475000},"page":"149590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Uncovering citron kinase as a key biomarker for predicting outcomes and therapy efficacy in non-muscle-invasive bladder cancer"],"prefix":"10.1016","volume":"963","author":[{"given":"Pei","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingkaiqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weide","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gene.2025.149590_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.gene.2025.149590_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.gene.2025.149590_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/JU.0000000000002957","article-title":"Clinical and preclinical therapies for bladder cancer following bacillus Calmette-Gu\u00e9rin failure","volume":"209","author":"Nazmifar","year":"2023","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.gene.2025.149590_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.gene.2025.149590_b0025","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","article-title":"Predicting response to intravesical bacillus Calmette-Gu\u00e9rin immunotherapy: are we there yet? a systematic review","volume":"73","author":"Kamat","year":"2018","journal-title":"Europ. Urol."},{"issue":"4","key":"10.1016\/j.gene.2025.149590_b0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.gene.2025.149590_b0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2025.149590_b0040","doi-asserted-by":"crossref","unstructured":"S. Bertz, W. Otto, S. Denzinger, W.F. Wieland, M. Burger, R. Sthr, S. Link, F. Hofstdter, A. Hartmann, Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer, European urology (65-1) (2014).","DOI":"10.1016\/j.eururo.2012.05.033"},{"key":"10.1016\/j.gene.2025.149590_b0045","article-title":"The values of HER-2 expression in the non-muscle-invasive bladder cancer: a retrospective clinical study","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.gene.2025.149590_b0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.euo.2023.10.003","article-title":"Prognostic Significance of HER2 Expression in Patients with Bacillus Calmette-Gu\u00e9rin\u2013exposed Non\u2013muscle-invasive Bladder Cancer","volume":"7","author":"Tan","year":"2024","journal-title":"European Urology Oncology"},{"key":"10.1016\/j.gene.2025.149590_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1301510","article-title":"HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion in EORTC risk-stratified cohort of bladder cancer","volume":"14","author":"Nam","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.gene.2025.149590_b0060","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.gene.2025.149590_b0065","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/2326-6066.CIR-16-0267","article-title":"Intravesical BCG induces CD4+ T-cell expansion in an immune competent model of bladder cancer","volume":"5","author":"Kates","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.gene.2025.149590_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615091","article-title":"Immunological hallmarks for clinical response to BCG in bladder cancer","volume":"11","author":"Lim","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2025.149590_b0075","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.gene.2025.149590_b0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.eururo.2020.06.048","article-title":"Identification of differential tumor subtypes of T1 bladder cancer","volume":"78","author":"Robertson","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2025.149590_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-3","article-title":"Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer","volume":"9","author":"Kim","year":"2010","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.gene.2025.149590_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"The Innovation"},{"issue":"2","key":"10.1016\/j.gene.2025.149590_b0095","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.gene.2025.149590_b0100","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/ijbs.77133","article-title":"M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy","volume":"19","author":"Zhong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.gene.2025.149590_b0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijbiomac.2018.06.005","article-title":"Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer","volume":"118","author":"Lu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.gene.2025.149590_b0110","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: A comprehensive, interaction\u2010friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","journal-title":"iMeta"},{"issue":"10","key":"10.1016\/j.gene.2025.149590_b0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.gene.2025.149590_b0120","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J. Urol."},{"issue":"6692","key":"10.1016\/j.gene.2025.149590_b0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/28873","article-title":"Role of citron kinase as a target of the small GTPase Rho in cytokinesis","volume":"394","author":"Madaule","year":"1998","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.gene.2025.149590_b0130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4161\/cc.6.13.4356","article-title":"ASPM and citron kinase co-localize to the midbody ring during cytokinesis","volume":"6","author":"Paramasivam","year":"2007","journal-title":"Cell Cycle"},{"issue":"45","key":"10.1016\/j.gene.2025.149590_b0135","doi-asserted-by":"crossref","first-page":"29706","DOI":"10.1074\/jbc.273.45.29706","article-title":"Citron rho-interacting kinase, a novel tissue-specific ser\/thr kinase encompassing the Rho-Rac-binding protein Citron","volume":"273","author":"Di Cunto","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2025.149590_b0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00439-016-1722-2","article-title":"Mutations in CIT, encoding citron rho-interacting serine\/threonine kinase, cause severe primary microcephaly in humans","volume":"135","author":"Shaheen","year":"2016","journal-title":"Hum. Genet."},{"issue":"2","key":"10.1016\/j.gene.2025.149590_b0145","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2016.07.004","article-title":"Biallelic mutations in citron kinase link mitotic cytokinesis to human primary microcephaly","volume":"99","author":"Li","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.gene.2025.149590_b0150","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/bloodadvances.2018028456","article-title":"Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma","volume":"3","author":"Sahin","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.gene.2025.149590_b0155","doi-asserted-by":"crossref","unstructured":"W. Lu, Y. Dong, Q. Cui, Y. Wang, M. Zhang, High expression of citron kinase contributes to the development of esophageal squamous cell carcinoma, Front. Genet. 12 628547.","DOI":"10.3389\/fgene.2021.628547"},{"issue":"42","key":"10.1016\/j.gene.2025.149590_b0160","doi-asserted-by":"crossref","first-page":"71954","DOI":"10.18632\/oncotarget.18615","article-title":"Up-regulation of CIT promotes the growth of colon cancer cells","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.gene.2025.149590_b0165","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.7150\/jca.43435","article-title":"Overexpression of citron rho-interacting serine\/threonine kinase associated with poor outcome in bladder cancer","volume":"11","author":"Shou","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.gene.2025.149590_b0170","doi-asserted-by":"crossref","unstructured":"Liu Z, HaiyanYang, YangWei, LiangjunXia, ShunyaoXiu, Youcheng, Down-regulation of CIT can inhibit the growth of human bladder cancer cells, Biomed Pharmacother Biomed Pharmacother 124 (2020).","DOI":"10.1016\/j.biopha.2020.109830"},{"issue":"4","key":"10.1016\/j.gene.2025.149590_b0175","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1074\/jbc.M210391200","article-title":"Citron Kinase Is a Cell Cycle-dependent, Nuclear Protein Required for G2\/M Transition of Hepatocytes","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.gene.2025.149590_b0180","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.gene.2025.149590_b0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8+ T cell subsets in antitumor immunity","volume":"30","author":"Paul","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"4","key":"10.1016\/j.gene.2025.149590_b0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"Van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"137","key":"10.1016\/j.gene.2025.149590_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Biot","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.gene.2025.149590_b0200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2022.09.008","article-title":"Elevated T-cell exhaustion and urinary tumor DNA levels are associated with Bacillus Calmette-Gu\u00e9rin failure in patients with non\u2013muscle-invasive bladder cancer","volume":"82","author":"Strandgaard","year":"2022","journal-title":"Eur. Urol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925003798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925003798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T13:05:48Z","timestamp":1753362348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111925003798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S0378111925003798"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149590","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering citron kinase as a key biomarker for predicting outcomes and therapy efficacy in non-muscle-invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149590"}}